MTOR and cancer: Currently, 2-hydroxyglutarate serves as an oncometabolite found in cancers like kidney, hematopoietic, and neurocrine cancer, in which its mutation promotes HIF-1 and mTOR signaling pathway alterations as well as DNA repair disruptions [37].